Home NDC 0363-2529-67 Bronchial Asthma Relief
Product NDC 0363-2529
Requested package NDC 0363-2529-67
11-digit product format 003632529
Labeler code 0363
Product ID 0363-2529_bcb71dc3-3e98-de10-e053-2a95a90a41ac
Type HUMAN OTC DRUG
Nonproprietary name Ephedrine HCl, Guaifenesin
Dosage form TABLET
Route ORAL
Labeler Walgreen Company
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2002-02-13
Marketing end 2023-04-30
Substance EPHEDRINE HYDROCHLORIDE; GUAIFENESIN
Active strength 13 mg/1; mg/1
Pharmacologic classes Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Norepinephrine Activity [PE], Increased Respiratory Secretions [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 19 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded EPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT NLJ6390P1Z BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 GUAIFENESIN ACTIVE INGREDIENT 495W7451VQ BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 EPHEDRINE ACTIVE MOIETY GN83C131XS BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 GUAIFENESIN ACTIVE MOIETY 495W7451VQ BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 MALTODEXTRIN INACTIVE INGREDIENT 7CVR7L4A2D BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 POVIDONE INACTIVE INGREDIENT FZ989GH94E BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP BRONCHIAL ASTHMA RELIEF (EPHEDRINE HCL, GUAIFENESIN) TABLET [WALGREENS COMPANY] 3
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0363-2529-67 00363252967 4 BLISTER PACK in 1 CARTON (0363-2529-67) > 15 TABLET in 1 BLISTER PACK 4 blister pack 2002-02-13 2023-04-30 No No Current